OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >...

Mastercard announced the launch of its Africa Cybersecurity Center of Excellence, a pan-African initiative designed to strengthen cyber resilience, enhance collaboration and help safeguard the trust that underpins Africa's expanding digital economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629910205/en/Michael Miebach, CEO, Mastercard unveiling The Cybersecurity Center of Excellence in Johannesburg, South Africa on Thursday...